14:40 IST
BSE
Financial Results
iSERA Lifesciences Q1 FY27 Results: Net Loss of ₹0.3 Cr
iSERA Lifesciences Ltd reported a net loss of ₹0.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.3 Cr
iSERA Lifesciences Ltd
- Share price
- ₹143.90
- Market cap
- ₹121.0 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹0.26 Cr
- P/E (TTM)
- 466.5×Sector 21.6×
- Promoter holding
- 58.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 5Other Announcement 4Financial Results 3Board Meeting Outcome 3Board Meeting Date 2Capital Structure Change 1Annual Report 1Acquisition 1
Time
3 announcements with these filters
19:55 IST
BSE
Financial Results
Covidh Technologies Q4 FY26 Results: Net Profit ₹0.5 Cr, Up 150.0% YoY
Covidh Technologies Ltd reported revenue from operations of ₹1.2 Cr and net profit of ₹0.5 Cr (+150.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.5 Cr · +150.0% YoY
19:55 IST
BSE
Financial Results
Covidh Technologies Financial Results
iSERA Lifesciences reported an audited annual net profit of ₹0.26 Crore for FY2026. The board also approved standalone results and noted a successful ₹8.08 Crore rights issue.
- Value
- ₹0.26 Cr